Jessica A. Rowley
Slough, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Biotransformation research advances-2025 year in review.
Journal: Drug metabolism reviews
Published: April 30, 2026
Efficacy and safety of fibrinogen concentrate (BT524) in severe hemorrhage: Phase 3 subcohort analysis of the AdFIrst trial in patients undergoing cytoreductive surgery for pseudomyxoma peritonei.
Journal: Journal of clinical anesthesia
Published: December 15, 2025
Biotransformation research advances - 2023 year in review.
Journal: Drug metabolism reviews
Published: July 11, 2024
Bioactivation and reactivity research advances - 2023 year in review.
Journal: Drug metabolism reviews
Published: July 04, 2024
Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy.
Journal: Bioorganic & medicinal chemistry
Published: April 04, 2022
Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators.
Journal: ACS medicinal chemistry letters
Published: July 20, 2020
2-Arylbenzo[d]oxazole Phosphinate Esters as Second-Generation Modulators of Utrophin for the Treatment of Duchenne Muscular Dystrophy.
Journal: Journal of medicinal chemistry
Published: June 20, 2020
Isolation, Structural Identification, Synthesis, and Pharmacological Profiling of 1,2-trans-Dihydro-1,2-diol Metabolites of the Utrophin Modulator Ezutromid.
Journal: Journal of medicinal chemistry
Published: October 11, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026